Hunan Er-Kang Pharmaceutical Co (SZSE:300267) Dividend Yield % : 0.00% (As of Apr. 10, 2025)

View and export this data going back to 2011. Start your Free Trial

What is Hunan Er-Kang Pharmaceutical Co Dividend Yield %?

As of today (2025-04-10), the Trailing Annual Dividend Yield of Hunan Er-Kang Pharmaceutical Co is 0.00%.

The historical rank and industry rank for Hunan Er-Kang Pharmaceutical Co's Dividend Yield % or its related term are showing as below:

During the past 13 years, the highest Dividend Yield of Hunan Er-Kang Pharmaceutical Co was 1.59%. The lowest was 0.00%. And the median was 0.35%.

SZSE:300267's Dividend Yield % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 1.945
* Ranked among companies with meaningful Dividend Yield % only.

Hunan Er-Kang Pharmaceutical Co's Dividend Payout Ratio for the three months ended in Sep. 2024 was 0.00.

During the past 13 years, the highest Dividend Payout Ratio of Hunan Er-Kang Pharmaceutical Co was 0.25. The lowest was 0.04. And the median was 0.11.

As of today (2025-04-10), the Forward Dividend Yield % of Hunan Er-Kang Pharmaceutical Co is 0.00%.

Hunan Er-Kang Pharmaceutical Co's Dividends per Share for the three months ended in Sep. 2024 was ¥0.00.

During the past 12 months, Hunan Er-Kang Pharmaceutical Co's average Dividends Per Share Growth Rate was -100.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 44.20% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Hunan Er-Kang Pharmaceutical Co was 56.70% per year. The lowest was -41.50% per year. And the median was 4.75% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Hunan Er-Kang Pharmaceutical Co Dividend Yield % Historical Data

The historical data trend for Hunan Er-Kang Pharmaceutical Co's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Er-Kang Pharmaceutical Co Dividend Yield % Chart

Hunan Er-Kang Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dividend Yield %

Get a 7-Day Free Trial

0.19

0.24

1.05

0.93

Hunan Er-Kang Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Dividend Yield %	Get a 7-Day Free Trial															0.88	0.93	1.11	1.44	-

Competitive Comparison of Hunan Er-Kang Pharmaceutical Co's Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Hunan Er-Kang Pharmaceutical Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hunan Er-Kang Pharmaceutical Co's Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hunan Er-Kang Pharmaceutical Co's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Hunan Er-Kang Pharmaceutical Co's Dividend Yield % falls into.

Save Embed

;

Save Embed

;

Hunan Er-Kang Pharmaceutical Co Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Hunan Er-Kang Pharmaceutical Co (SZSE:300267) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Hunan Er-Kang Pharmaceutical Co Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Hunan Er-Kang Pharmaceutical Co's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hunan Er-Kang Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Er-Kang Pharmaceutical Co Ltd (SZSE:300267) » Definitions » Dividend Yield %

Traded in Other Exchanges

N/A

Address

Kangping Road 167, National Economic and Technological Development Zone, Liuyang Changsha, Hunan, CHN, 410331

Website

http://www.hnerkang.com

Hunan Er-Kang Pharmaceutical Co Ltd develops, produces and sells pharmaceutical products in China. The company's main products include pharmaceutical excipients and antibiotics. It offers pharmaceutical excipients, APIs and finished drug products. The pharmaceutical excipients include products such as glycerol, ethanol pharmaceutically, acceptable propylene glycol, sodium hydroxide, and pharmaceutically acceptable sugar. The company's finished drugs primarily include sulbenicillin sodium for injection and compound liquorice tablets. Its APIs include glycerin, dilute hydrochloric acid, dihydroxypropyl theophylline, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. Geographically, all the activities are carried out through China.

Executives

Shuai Fang Wen	Director
Wang Jun Wen	Independent director
Zuo Tian Fang	Independent director
Qi Yang	Supervisors
Li Yi Guo	Supervisors
Chen Wen Xian	Supervisors
Wang Xiang Feng	Directors, executives
Liu Ai Jun	Directors, executives
Luo Lang	Directors, executives
Fan Yi	Securities Affairs Representative
Yang Hai Ming	Directors, executives
Shuai You Wen	Director
Shuai Rui Wen	Director
Gao Zhen Ya	Executives
Cao Zai Yun	Director

Hunan Er-Kang Pharmaceutical Co Headlines

No Headlines